Rocuronium and other steroidal neuromuscular blocking agents — Drug Target

All drugs that target Rocuronium and other steroidal neuromuscular blocking agents — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Selective relaxant binding agent

Phase 3 pipeline (1)

• Placebo to sugammadex · Merck Sharp & Dohme LLC · Selective relaxant binding agent · Anesthesia
  Sugammadex is a selective relaxant binding agent that encapsulates rocuronium and other neuromuscular blocking agents, rapidly reversing neuromuscular blockade.